Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Prelude Therapeutics Inc
About PRLD
Prelude Therapeutics Incorporated is a precision oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. By focusing on developing molecules using broad mechanisms that have multiple links to oncogenic driver pathways in select patients, it has developed a diverse pipeline consisting of multiple distinct programs, including kinases, targeted protein degraders, and degrader antibody conjugates. PRT12396 its lead, mutant-selective JAK2V617F inhibitor, is an open-label and multi-center study in patients with high-risk polycythemia vera and intermediate and high-risk myelofibrosis. JAK2V617F is the primary driver mutation responsible for disease progression in the majority of patients living with myeloproliferative neoplasms. The Company has discovered and is developing a series of selective and orally bioavailable KAT6A selective degraders. KAT6A is engaged in treating advanced breast cancer & other solid tumors.
Find out what a historical investment in Prelude Therapeutics Inc would be worth today using our PRLD stock calculator.
Market Capitalisation
$356.81M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
472.17K
High today
$4.60
Low today
$4.10
Open price
$4.33
52-week high
$5.54
52-week low
$0.75
Ready to start your investing journey with Stake?
Open an accountHow do I buy PRLD shares in Australia?
Buying PRLD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Prelude Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PRLD
What is the ticker symbol of Prelude Therapeutics Inc?
The ticker symbol for Prelude Therapeutics Inc is PRLD.
How much is one share of PRLD?
One share of PRLD is valued at $4.49 as of 16 May 2026.
What is the market capitalisation of Prelude Therapeutics Inc PRLD?
As of 16 May 2026 Prelude Therapeutics Inc has a market cap of $356.81M.
What is the 52-week high for Prelude Therapeutics Inc stock?
The Prelude Therapeutics Inc 52-week high stock price is $5.54.
What is the 52-week low for Prelude Therapeutics Inc stock?
The Prelude Therapeutics Inc 52-week low stock price is $0.75.
Can I buy PRLD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PRLD shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PRLD on Stake
- Buy PRLD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PRLD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PRLD related stocks